REFANA Trademark

Trademark Overview

On Friday, December 11, 2020, a trademark application was filed for REFANA with the United States Patent and Trademark Office. The USPTO has given the REFANA trademark a serial number of 90376456. The federal status of this trademark filing is REGISTERED as of Tuesday, May 2, 2023. This trademark is owned by Refana, Inc.. The REFANA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines
refana

General Information

Serial Number90376456
Word MarkREFANA
Filing DateFriday, December 11, 2020
Status700 - REGISTERED
Status DateTuesday, May 2, 2023
Registration Number7043635
Registration DateTuesday, May 2, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements

Translation of Words in MarkThe English translation of "REFANA" in the mark is "Please Heal".
Goods and ServicesResearch and development of vaccines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 19, 2021
Primary Code042
First Use Anywhere DateThursday, June 30, 2022
First Use In Commerce DateThursday, June 30, 2022

Trademark Owner History

Party NameRefana, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLas Vegas, NV 89117
Party NameRefana, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLas Vegas, NV 89117
Party NameRefana, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHighland Park, NJ 08904

Trademark Events

Event DateEvent Description
Tuesday, May 2, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 2, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, March 25, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 24, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 23, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, March 6, 2023USE AMENDMENT FILED
Wednesday, March 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 6, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, March 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2022SOU EXTENSION 2 GRANTED
Tuesday, September 6, 2022SOU EXTENSION 2 FILED
Tuesday, September 6, 2022TEAS EXTENSION RECEIVED
Wednesday, March 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 7, 2022SOU EXTENSION 1 GRANTED
Monday, March 7, 2022SOU EXTENSION 1 FILED
Monday, March 7, 2022TEAS EXTENSION RECEIVED
Tuesday, September 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 3, 2021ASSIGNED TO EXAMINER
Friday, February 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 15, 2020NEW APPLICATION ENTERED

Related Keywords

refana vaccines development research